Abstract Submission Guidelines

What information should you be prepared to include in your abstract submission? 

The abstract should be in English, text only (no graphics) and include the following information: 

  • Topic – Please select one of the disease tracks (e.g., typhoid, paratyphoid, iNTS, or enteric fever) 
  • Abstract Title – Should not exceed 160 characters 
  • Keywords – Up to 5 keywords, separated by a semicolon (;) 
  • Primary & Secondary Thematic Track – Please select the thematic track(s) that best characterizes the area of research your submission is contributing to (e.g.,  Antimicrobial Resistance, Clinical Research, Diagnostics, Epidemiology, Genomics, Health Economics, Impact Studies, Modeling, Policy, Vaccine Development, Vaccine Introduction, and/or WASH) 
  • Preferred Presentation Method – Select one (e.g., oral, poster, either) 
  • Co-Authors - No limit
  • Abstract – Should not exceed 500 words 
    • Background:  State the purpose and objective of the research or program, as well as a description of the problem being analyzed 
    • Methodology:  Describe the basic design of the study, including the study period, setting, design, population and techniques used for data collection 
    • Results: Report the key findings that address the purpose of the study. Highlight any statistically significant differences or trends found in the data 
    • Conclusions: Summarize the overall findings and explain the significance and future implications of the results 
  • Highlights – In 3 short bullets, please highlight the main contributions of your research. Should not exceed 50 words 

All abstracts need to adhere to these requirements and must be submitted through our online submission center to be considered. 

What are the selection criteria? 

Abstracts will be evaluated and accepted on the basis of their relevance as well as their scientific quality. The Abstract Review Panel will grade the abstracts against the following criteria: 

  • Is there a clear background and justified objective? 
  • Is the methodology appropriate for the objectives? 
  • Are the results important and clearly presented? 
  • Are the conclusions supported by the results? 
  • Does the study contribute to the field of typhoid, paratyphoid and/or iNTS disease? 

When will I be notified if my abstract has been accepted? 

Letters of acceptance/rejection will be sent end of October.